We Lifescience Intellipedia is one of the largest pharmaceutical markets in the world . The COVID-19 impact, an ageing population and increasing chronic disease cases have drawn the attention of the Japanese government to the healthcare sector. Observing the difficulties faced in developing vaccines to combat the COVID-19 pandemic, Japan has given top priority to the research of novel drugs and vaccines. The branded drug market in Japan experienced significant developments and transformations from 2020 to 2022. Over the years, the Pharmaceuticals and Medical Devices Agency (PMDA), has been actively involved in accelerating the approval timelines for new drugs and medical devices. As per reports, in the fiscal year 2020–2022, PMDA approved approximately 148 novel drugs across various therapeutic categories. These new drug approvals provided patients with access to advanced treatment options and contributed to addressing unmet medical needs. Pharmaceutical companies, including glob...